Close

“Spider-Man: No Way Home” Snags Record Advance Ticket Sales

The first Tom Holland-led Spider-Man trilogy (there will be a second) is about to come to an end with the release of Spider-Man: No Way Home, and unsurprisingly, people are very excited to see it in the theater. The demand for advanced tickets, which went on sale on November 29, has been such that the rush of would-be buyers crashed a few of the online sites selling tickets. Hundreds upon hundreds of theaters sold out more or less immediately. Theater owners across the country are scrambling to add as many screenings as their venues can handle. This, folks, is called major movie enthusiasm.

Fandango has reported that Spider-Man: No Way Home has broken its pre-sale records for 2021, besting Marvel’s Black Widow. It’s also doing remarkably well against films that came out before COVID-19, notching the best first-day advance ticket sales since the Russo Brothers’ Avengers: Endgame in 2019. Fandango currently has No Way Home beating Avengers: Infinity War, Spider-Man: Far From Home, Star Wars: The Last Jedi, and Star Wars: The Rise of Skywalker. While first-day advance ticket sales don’t always equate to record opening weekends, these numbers are a very good sign.

It’s also hugely welcome news for a theater industry that was hit incredibly hard by the pandemic. The final months of 2021 have seen a welcome surge of big movies bringing in big audiences, with Shang-Chi and the Legend of the Ten Rings starting things off in September, and then that historic October, with No Time To Die, Venom: Let There Be Carnage, Halloween Kills, and Dune all bringing in huge crowds.

There is, of course, a new threat to the movie business—Omicron, the newest strain of COVID-19, which has the potential to create a new spike in cases. The little known about this new variant makes it harder for people to make decisions about whether to continue doing the things they’ve longed to resume, like going to the movies. As for now, it seems vaccinated people are choosing the movies over their fear of the new variant.

There are also several reasons that No Way Home is such a strong draw for superhero-loving audiences—Spider-Man is a known and beloved quantity, whereas audiences were just meeting Shang-Chi (Simu Liu) and the entire cast of new superheroes in Chloé Zhao’s Eternals. Then you can add the fact that No Way Home is kind of a super-sized Spider-Man movie, with villains from previous franchises, including Alfred Molina’s Doc Ock and Jamie Foxx’s Electro, bursting back into the scene.

We’ll see how this all plays out in the weeks ahead as more is learned about the new variant, but for now, Spider-Man is swinging high.

Spider-Man: No Way Home opens on December 17.

For more on Spider-Man: No Way Home, check out these stories:

Villains Reign Supreme in New “Spider-Man: No Way Home” Images

Villains Reign Supreme in New “Spider-Man: No Way Home” Images

“Spider-Man: No Way Home” Official Trailer Reveals Even More Villains

New “Spider-Man: No Way Home” Poster Reveals the Green Goblin

New “Spider-Man: No Way Home” Images Reveal Doc Ock

First “Spider-Man: No Way Home” Images Reveal Peter Parker’s Multiverse Adventure

“Spider-Man: No Way Home” Trailer Reveals Peter Parker’s Strange Trip

Featured image: Tom Holland is Spider-Man and Zendaya is MJ in “Spider-Man: No Way Home.” Courtesy Sony Pictures.

ABOUT THE AUTHOR

The Credits

The Credits is an online magazine that tells the story behind the story to celebrate our large and diverse creative community. Focusing on profiles of below-the-line filmmakers, The Credits celebrates the often uncelebrated individuals who are indispensable to the films and TV shows we love.

The Credits

Keep up with The Credits for the latest in film, television, and streaming.

If you are a California resident, California law may consider certain disclosures of data a “sale” of your personal information (such as cookies that help Motion Picture Association later serve you ads, like we discuss in our Privacy Policy here), and may give you the right to opt out. If you wish to opt out, please click here: